ArticleBritish journal of cancer2018

Pathological complete response and prognosis after neoadjuvant chemotherapy for HER2-positive breast cancers before and after trastuzumab era: results from a real-life cohort.

Anne-Sophie Hamy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.